
Traviss C. Mcintosh Iii
Examiner (ID: 1990, Phone: (571)272-0657 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1621, 1693, 1623, 1673 |
| Total Applications | 1933 |
| Issued Applications | 1263 |
| Pending Applications | 174 |
| Abandoned Applications | 514 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18886372
[patent_doc_number] => 11865128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Aminoglycosides and uses thereof in treating genetic disorders
[patent_app_type] => utility
[patent_app_number] => 17/226050
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 59
[patent_no_of_words] => 30943
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17226050
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/226050 | Aminoglycosides and uses thereof in treating genetic disorders | Apr 7, 2021 | Issued |
Array
(
[id] => 17726561
[patent_doc_number] => 11382926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Methods for treating
[patent_app_type] => utility
[patent_app_number] => 17/222066
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 44751
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222066
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/222066 | Methods for treating | Apr 4, 2021 | Issued |
Array
(
[id] => 19157680
[patent_doc_number] => 20240150387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => GLUCOCEREBROSIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/279150
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279150
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279150 | GLUCOCEREBROSIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | Apr 1, 2021 | Pending |
Array
(
[id] => 16977599
[patent_doc_number] => 20210221836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
[patent_app_type] => utility
[patent_app_number] => 17/221201
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221201 | IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS | Apr 1, 2021 | Abandoned |
Array
(
[id] => 20357339
[patent_doc_number] => 12473322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Polymeric amphoteric surfactant compound
[patent_app_type] => utility
[patent_app_number] => 17/915843
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 0
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915843 | Polymeric amphoteric surfactant compound | Mar 30, 2021 | Issued |
Array
(
[id] => 20453032
[patent_doc_number] => 12516082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Metal-carbohydrate complex
[patent_app_type] => utility
[patent_app_number] => 17/915822
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 1857
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915822 | Metal-carbohydrate complex | Mar 30, 2021 | Issued |
Array
(
[id] => 18685154
[patent_doc_number] => 11780871
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-10
[patent_title] => COVID-19 treatment and methods
[patent_app_type] => utility
[patent_app_number] => 17/215839
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3848
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17215839
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/215839 | COVID-19 treatment and methods | Mar 28, 2021 | Issued |
Array
(
[id] => 18399310
[patent_doc_number] => 11661436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Method for preparing 3'-o-amino-2'-deoxyribonucleoside-5'-triphosphates
[patent_app_type] => utility
[patent_app_number] => 17/214245
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1733
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/214245 | Method for preparing 3'-o-amino-2'-deoxyribonucleoside-5'-triphosphates | Mar 25, 2021 | Issued |
Array
(
[id] => 18337761
[patent_doc_number] => 20230129710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => Methods and Reagents for Synthesizing Nucleosides and Analogues Thereof
[patent_app_type] => utility
[patent_app_number] => 17/913920
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913920 | Methods and Reagents for Synthesizing Nucleosides and Analogues Thereof | Mar 24, 2021 | Pending |
Array
(
[id] => 19447295
[patent_doc_number] => 20240307425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATING SEPSIS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/272466
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272466
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272466 | PHARMACEUTICAL COMPOSITION FOR TREATING SEPSIS AND USE THEREOF | Mar 22, 2021 | Pending |
Array
(
[id] => 17110055
[patent_doc_number] => 20210290652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-dG, CHECKPOINT INHIBITORS AND RADIATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/200539
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200539
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200539 | Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy | Mar 11, 2021 | Issued |
Array
(
[id] => 18348066
[patent_doc_number] => 20230136177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => IMMUNOMODULATING O-HET/ARYL AZALIDES
[patent_app_type] => utility
[patent_app_number] => 17/801340
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 759
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801340
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801340 | Immunomodulating o-het/aryl azalides | Mar 10, 2021 | Issued |
Array
(
[id] => 18413128
[patent_doc_number] => 11667661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same
[patent_app_type] => utility
[patent_app_number] => 17/195425
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5899
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17195425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/195425 | Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same | Mar 7, 2021 | Issued |
Array
(
[id] => 17604019
[patent_doc_number] => 11332490
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-17
[patent_title] => Compounds and methods for treating osteoarthritis
[patent_app_type] => utility
[patent_app_number] => 17/182156
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 14882
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182156
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182156 | Compounds and methods for treating osteoarthritis | Feb 21, 2021 | Issued |
Array
(
[id] => 18610846
[patent_doc_number] => 20230277576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => A METHOD FOR PREVENTING OR TREATING A CORNAVIRUS INFECTIOUS DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/905142
[patent_app_country] => US
[patent_app_date] => 2021-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905142 | A METHOD FOR PREVENTING OR TREATING A CORNAVIRUS INFECTIOUS DISEASE | Feb 19, 2021 | Pending |
Array
(
[id] => 18326513
[patent_doc_number] => 20230124641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => CROSS-LINKED NUCLEOSIDE AND NUCLEOTIDE USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/800339
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/800339 | Cross-linked nucleoside and nucleotide using same | Feb 16, 2021 | Issued |
Array
(
[id] => 18320940
[patent_doc_number] => 20230119068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS
[patent_app_type] => utility
[patent_app_number] => 17/799393
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799393
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799393 | METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS | Feb 15, 2021 | Pending |
Array
(
[id] => 17213079
[patent_doc_number] => 20210346415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/176450
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176450
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176450 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | Feb 15, 2021 | Abandoned |
Array
(
[id] => 18748552
[patent_doc_number] => 11807851
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-07
[patent_title] => Modified polynucleotides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/176617
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 46067
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 605
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176617
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176617 | Modified polynucleotides and uses thereof | Feb 15, 2021 | Issued |
Array
(
[id] => 17256770
[patent_doc_number] => 20210369755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => 4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
[patent_app_type] => utility
[patent_app_number] => 17/174726
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174726
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/174726 | 4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication | Feb 11, 2021 | Abandoned |